CRYPTIVAX
LIVE

Serial Number

99118774

Owner

Epitopea Ltd.

Attorney

Scott Locke

Filing Date

Apr 3, 2025

Add to watchlist:

No watchlists yet
View on USPTO

CRYPTIVAX Trademark

Serial Number: 99118774

CRYPTIVAX is a trademark filed by Epitopea Ltd. on April 3, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Epitopea Ltd. (3 trademarks)

Station Road
Cambridge CB12LA , GB

Entity Type: 16

Epitopea Inc. (3 trademarks)

2950 Chemin de Polytechnique
Montreal, Quebec H3T1J4 , CA

Entity Type: 03

Trademark Details

Filing Date

April 3, 2025

Registration Date

Not Registered

Published for Opposition

November 18, 2025

Goods & Services

Research and development in the field of cancer; research and development in the field of immunology; scientific research for medical purposes in the field of oncology; scientific research for medical purposes in the field of immunology; Biological research services; Pharmaceutical research services; pharmaceutical, biologic and immunological drug and vaccine development services; providing scientific research information and data relating to oncology and immunology; advisory and consultancy services related to scientific research in the fields of oncology oncology and immunology

Immunoassay reagents for medical use; Pharmaceutical products for the prevention and treatment of cancer; vaccines for the treatment of cancer; vaccines for the prevention of cancer; antigens in the nature of tumor antigens for medical use; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; vaccines for regulating the immune system; pharmaceutical preparations for treatment in the nature of regulating the immune system; proteins with diagnostic and therapeutic uses, namely arrays and solutions of proteins for diagnosing cancer and diseases and disorders of the immune system; Antibodies for medical purposes; vaccines for the prevention and treatment of immune system related diseases and disorders

Active chemical ingredients for use in the manufacture of anti-cancer therapeutics and vaccines; monoclonal antibodies for scientific purposes; nucleotides for scientific and research use; Chemicals, reagents and substances being peptides, nucleic acids and buffers for medical research purposes; proteins, namely arrays, monoclonal antibodies and enzymes for scientific and research use

Filing History

TEAS DELETE 1(B) BASIS RECEIVED
Jan 21, 2026 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 13, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 12, 2025 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Oct 10, 2025 PBCR
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 8, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 18, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 17, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 17, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 17, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 3, 2025 GNRN
NON-FINAL ACTION E-MAILED
Sep 3, 2025 GNRT
NON-FINAL ACTION WRITTEN
Sep 3, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 1, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 11, 2025 NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 11, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Apr 3, 2025 MAFR
NEW APPLICATION ENTERED
Apr 3, 2025 NWAP